Zobrazeno 1 - 10
of 61
pro vyhledávání: '"C. Suárez‐Cuervo"'
Publikováno v:
Neurología, Vol 35, Iss 4, Pp 264-265 (2020)
Externí odkaz:
https://doaj.org/article/ebc30248d05743158f327564ae08574f
Publikováno v:
Neurología (English Edition), Vol 35, Iss 4, Pp 264-265 (2020)
Externí odkaz:
https://doaj.org/article/6d8468a7c0db4a75bb991726304f613b
Publikováno v:
Journal of Internal Medicine
We read with great interest the comment by Suarez‐Perez et al. on our article.[1] We share their concerns regarding the need for a cautious interpretation of antiphospholipid antibodies (aPLA) positivity in patients with coronary virus disease 2019
Publikováno v:
Neurología (English Edition), Vol 35, Iss 4, Pp 264-265 (2020)
Neurología (English Edition)
Neurología (English Edition)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
H, Gheitasi, B, Kostov, R, Solans, G, Fraile, C, Suárez-Cuervo, A, Casanovas, F J, Rascón, R, Qanneta, R, Pérez-Alvarez, M, Ripoll, M, Akasbi, B, Pinilla, J A, Bosch, J, Nava-Mateos, B, Díaz-López, M L, Morera-Morales, S, Retamozo, M, Ramos-Casals, P, Brito-Zerón, A, Sisó-Almirall
Publikováno v:
International immunopharmacology, 27(2), 194-199. Elsevier
Objective: To describe how systemic disease is treated in a large cohort of Spanish patients with primary Sjögren syndrome (pSS) in daily practice, focusing on the adequacy of therapies for the level of systemic activity measured by ESSDAI score.Pat
Autor:
P, Brito-Zerón, B, Kostov, R, Solans, G, Fraile, C, Suárez-Cuervo, A, Casanovas, F J, Rascón, R, Qanneta, R, Pérez-Alvarez, M, Ripoll, M, Akasbi, B, Pinilla, J A, Bosch, J, Nava-Mateos, B, Díaz-López, M L, Morera-Morales, H, Gheitasi, S, Retamozo, M, Ramos-Casals, A, Sisó-Almirall
Publikováno v:
Annals of the Rheumatic Diseases. 75:348-355
Objective To score systemic activity at diagnosis and correlate baseline activity with survival in a large cohort of patients with primary Sjogren syndrome (SS). Patients and methods We include 1045 consecutive patients who fulfilled the 2002 classif
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
R. Qanneta, Soledad Retamozo, L. Morera-Morales, Roberto Pérez-Alvarez, A. Casanovas, P. Brito Zeron, J. Nava-Mateos, Manuel Ramos-Casals, H. Gheitasi, Blanca Pinilla, Xavier Bosch, M. Ripoll, M. Akasbi, R. Solans, B. Kostov, B. Díaz-Lόpez, C. Suárez-Cuervo, F.-J. Rascόn, Guadalupe Fraile
Publikováno v:
Annals of the Rheumatic Diseases. 74:344.2-344
Objectives To describe how systemic disease is treated in a large cohort of Spanish patients with primary Sjogren syndrome in daily practice, focusing on the adequacy of drug therapies for the level of systemic activity measured by the ESSDAI score.
Autor:
R. Solans, R. Qanneta, Soledad Retamozo, Blanca Pinilla, C. Suárez-Cuervo, L. Morera-Morales, M. Ripoll, F.-J. Rascόn, Guadalupe Fraile, H. Gheitasi, Manuel Ramos-Casals, Marta Perez-de-Lis, B. Kostov, M. Akasbi, P. Brito Zeron
Publikováno v:
Annals of the Rheumatic Diseases. 73:143.1-143
Objectives To analyse the association between the new 2010 EULAR-SS disease activity index (ESSDAI) and death in a large cohort of Spanish patients with primary Sjogren syndrome (pSS) Methods The GEAS-SS multicenter registry was formed in 2005 with t